If Theranos hadn't falsified anything, would they have had a product? My recollection, having read _Bad Blood_, is that they would not.
Good intentions to save the world, without any working (or even possible!) technology, are not investment-worthy.
Good intentions to save the world, without any working (or even possible!) technology, are not investment-worthy.
But there's a wide gulf between a drop and a 20mL vial. Requiring three drops and claiming half the battery of tests would still be a substantial improvement. That's what they should've done. And I think this new startup can do that.
I interviewed with Theranos toward the very end. I have never been in a place with a bigger show of security, and I've previously worked for years in nuclear weapons laboratories. If this new startup ditches the demonic-possession voice and the arch-military security schtick, and the Wizard of Oz curtain, I might not consider an investment in them as foolhardy as one in Theranos.